4//SEC Filing
Parsey Merdad 4
Accession 0001127602-24-029171
CIK 0000882095other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 7:24 PM ET
Size
8.3 KB
Accession
0001127602-24-029171
Insider Transaction Report
Form 4
Parsey Merdad
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2024-12-10$92.34/sh−1,771$163,534→ 82,850 total - Exercise/Conversion
Common Stock
2024-12-10+3,820→ 84,621 total - Exercise/Conversion
Restricted Stock Unit
2024-12-10−3,820→ 36,753 total→ Common Stock (3,820 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.
Documents
Issuer
GILEAD SCIENCES, INC.
CIK 0000882095
Entity typeother
Related Parties
1- filerCIK 0001792150
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 7:24 PM ET
- Size
- 8.3 KB